Now on ScienceBlogs: Freethinker Sunday Sermonette: more religion and child abuse
Stronger. Faster. Bloggier. Now chock full of glial goodness. **Warning** contains neuro-nuts.
The Evil Monkey has a Ph.D. in Neuroscience from a southeastern U.S. university. After a postdoctoral nightmare of Inquisitorial proportions, he is currently working in a laboratory and an adjunct assistant professor at a nearby state university.
Scicurious is a graduate student wrestling with a PhD in Physiology at a southern institution. She is a nerd, a geek, and also a dork. And yes, that really is her brain.
NotoriousLTP is an MD-PhD student in New York City. After finishing (hopefully soon) his PhD in behavioral neuroscience, he will re-enter the fun vortex that is medical education.
Disclaimer: The opinions on this blog do not represent any organization to which we may belong, or employers, or basically anybody but us. So there.
Category: Health Care/Medicine
The big problem, I would say, is that there's just so much out there that's just so sinfully sweet. Everything we eat is sweetened, whether it be with sugar or with HFCS, and we're eating and drinking far more sweetened stuff than any group of people has ever done before.
Posted by Scicurious at 12:25 AM • 47 Comments • 0 TrackBacks
Category: Health Care/Medicine
This is one of those weeks where there is SO much to blog about and so little time to do it in! How shall I ever get to it all! This article actually came out on Tuesday, which means of...
Posted by Scicurious at 3:29 PM • 10 Comments • 0 TrackBacks
Category: CNS Diseases and Disorders
Some people have been noticing erratic behavior from republican nominee John McCain lately. His most recent seems to be slight, but rather odd. Specifically, he appears to have developed ptosis--- a drooping eyelid--- which could of course be related to...
Posted by Evil Monkey at 12:40 PM • 7 Comments • 0 TrackBacks
...but for those who suffer from it, "in your head" can be more debilitating than other chronic, painful illnesses. A massive WHO survey study of 60 countries reported that 3.2% of people had depression over the course of a year....
Posted by Evil Monkey at 3:55 PM • 5 Comments • 0 TrackBacks
Finally we get some data on changes in AD pathology with statin use! Statins are taken for lowering cholesterol, but they have other beneficial effects such as modulating inflammatory responses. Thus, they could prove beneficial in the treatment of AD...
Posted by Evil Monkey at 3:50 PM • 2 Comments • 0 TrackBacks
I'm on a environmental tox kick lately. The latest foray into endocrine disruption in the news is polybrominated diphenyl ethers, or PBDEs. PBDEs are used as flame retardant compounds, and like my earlier ruminations on bisphenol A, they're in everything....
Posted by Evil Monkey at 1:50 PM • 0 Comments • 0 TrackBacks
Yes, that title is a bit ostentatious. But the foods we eat contain many compounds that can be beneficial to brain health. One strategy for optimizing our brains for long-term peak performance is to identify these compounds and discover how...
Posted by Evil Monkey at 3:03 PM • 3 Comments • 0 TrackBacks
Category: Menopause
I recently posted three "Basics"-style blurbs about menopause and hormone therapy (HT). If you missed it, they are here, here, and here. The field has gone through a lot of upheaval since the WHI studies in 2002, and I would...
Posted by Evil Monkey at 1:53 AM • 3 Comments • 0 TrackBacks
Category: Menopause
Postmenopausal women frequently complain about problems with attention and concentration, and increased forgetfulness. Controlled studies of the cognitive effects of menopause and HRT, however, have been controversial.
Posted by Evil Monkey at 1:05 AM • 3 Comments • 0 TrackBacks
Category: Menopause
This is the second of a series that examines menopause, hormone therapy, and consequences of each. Today's installment looks at the makeup of common hormones on the market, physiological consequences of hormone loss and replacement, and the Women's Health Initiative...
Posted by Evil Monkey at 2:45 PM • 2 Comments • 0 TrackBacks
